94 related articles for article (PubMed ID: 10806783)
41. Perifosine, a novel alkylphospholipid, induces p21(WAF1) expression in squamous carcinoma cells through a p53-independent pathway, leading to loss in cyclin-dependent kinase activity and cell cycle arrest.
Patel V; Lahusen T; Sy T; Sausville EA; Gutkind JS; Senderowicz AM
Cancer Res; 2002 Mar; 62(5):1401-9. PubMed ID: 11888912
[TBL] [Abstract][Full Text] [Related]
42. The clinicopathologic significance of p53 and p21 expression in the surgical management of lingual squamous cell carcinoma.
Yuen PW; Chow V; Choy J; Lam KY; Ho WK; Wei WI
Am J Clin Pathol; 2001 Aug; 116(2):240-5. PubMed ID: 11488071
[TBL] [Abstract][Full Text] [Related]
43. Endogenous p21WAF1/CIP1 status predicts the response of human tumor cells to wild-type p53 and p21WAF1/CIP1 overexpression.
Kralj M; Husnjak K; Körbler T; Pavelić J
Cancer Gene Ther; 2003 Jun; 10(6):457-67. PubMed ID: 12768191
[TBL] [Abstract][Full Text] [Related]
44. Prediction of lymph node metastasis by p53, p21(Waf1), and PCNA expression in esophageal cancer patients.
Ueno H; Hirai T; Nishimoto N; Hihara J; Inoue H; Yoshida K; Yamashita Y; Toge T; Tsubota N
J Exp Clin Cancer Res; 2003 Jun; 22(2):239-45. PubMed ID: 12866574
[TBL] [Abstract][Full Text] [Related]
45. Reduced p21(WAF1/CIP1) expression is an early event in gallbladder carcinogenesis and is of prognostic significance for patients with carcinomas of the gallbladder.
Li X; Hui AM; Shi YZ; Takayama T; Makuuchi M
Hum Pathol; 2001 Aug; 32(8):771-7. PubMed ID: 11521218
[TBL] [Abstract][Full Text] [Related]
46. [Expressions and their clinical significance of bcl-2 and nm23 in epithelial ovarian carcinoma].
Cao LQ; Chen XM; Li X
Hunan Yi Ke Da Xue Xue Bao; 2000 Apr; 25(2):188-90. PubMed ID: 12212220
[TBL] [Abstract][Full Text] [Related]
47. Different clinical roles for p21-activated kinase-1 in primary and recurrent ovarian carcinoma.
Davidson B; Shih IeM; Wang TL
Hum Pathol; 2008 Nov; 39(11):1630-6. PubMed ID: 18656238
[TBL] [Abstract][Full Text] [Related]
48. Loss of the expression of the tumor suppressor gene ARHI is associated with progression of breast cancer.
Wang L; Hoque A; Luo RZ; Yuan J; Lu Z; Nishimoto A; Liu J; Sahin AA; Lippman SM; Bast RC; Yu Y
Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3660-6. PubMed ID: 14506155
[TBL] [Abstract][Full Text] [Related]
49. [Relation between COX-2 protein expression and biologic behavior of ovarian carcinoma].
Tang LX; Wang M; Ma JW
Zhonghua Zhong Liu Za Zhi; 2003 May; 25(3):261-3. PubMed ID: 12839690
[TBL] [Abstract][Full Text] [Related]
50. Retinoblastoma protein expression in ovarian epithelial neoplasms.
Niemann TH; Trgovac TL; McGaughy VR; Lewandowski GS; Copeland LJ
Gynecol Oncol; 1998 Jun; 69(3):214-9. PubMed ID: 9648590
[TBL] [Abstract][Full Text] [Related]
51. Transforming growth factor-beta differentially inhibits epithelial ovarian carcinoma cells from primary and metastatic isolates without up-regulation of p21WAF1.
Hurteau JA; Allison B; Sutton GP; Moore DH; Look KY; Hurd W; Bigsby RM
Cancer; 1999 Apr; 85(8):1810-5. PubMed ID: 10223576
[TBL] [Abstract][Full Text] [Related]
52. [Expression and Clinical Significance of Numb and P53 Proteins in Epithelial Ovarian Carcinoma].
Xu M; He HJ; Zhang H; Wang A; Chen J
Sichuan Da Xue Xue Bao Yi Xue Ban; 2017 Jan; 48(1):76-80. PubMed ID: 28612563
[TBL] [Abstract][Full Text] [Related]
53. p21 and p53 in ovarian carcinoma: their combined staining is more valuable than either alone.
Geisler HE; Geisler JP; Miller GA; Geisler MJ; Wiemann MC; Zhou Z; Crabtree W
Cancer; 2001 Aug; 92(4):781-6. PubMed ID: 11550148
[TBL] [Abstract][Full Text] [Related]
54. [Expression and involved signal transduction pathway of autophagy gene Beclin 1 in epithelial ovarian cancer].
Duan ZL; Peng ZL; Wang ZH
Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Mar; 38(2):239-42. PubMed ID: 17441338
[TBL] [Abstract][Full Text] [Related]
55. [Incidence of proapoptotic proteins p53 and p21 in epithelial ovarian tumors].
Gajewska M; Wielgoś M; Panek G; Marczewska J
Ginekol Pol; 2014 Feb; 85(2):111-6. PubMed ID: 24745156
[TBL] [Abstract][Full Text] [Related]
56. A protective role for common p21WAF1/Cip1 polymorphisms in human ovarian cancer.
Milner BJ; Brown I; Gabra H; Kitchener HC; Parkin DE; Haites NE
Int J Oncol; 1999 Jul; 15(1):117-9. PubMed ID: 10375603
[TBL] [Abstract][Full Text] [Related]
57. Polymorphisms in P21CIP1/WAF1 are not correlated with TP53 status in sporadic ovarian tumours.
Milner BJ; Hosking L; Sun S; Haites NE; Foulkes WD
Eur J Cancer; 1996 Dec; 32A(13):2360-3. PubMed ID: 9038623
[TBL] [Abstract][Full Text] [Related]
58. NOEY2 (ARHI), an imprinted putative tumor suppressor gene in ovarian and breast carcinomas.
Yu Y; Xu F; Peng H; Fang X; Zhao S; Li Y; Cuevas B; Kuo WL; Gray JW; Siciliano M; Mills GB; Bast RC
Proc Natl Acad Sci U S A; 1999 Jan; 96(1):214-9. PubMed ID: 9874798
[TBL] [Abstract][Full Text] [Related]
59. Diagnostic approach using the expression profiling of the P53 tumor suppressor gene and its related proteins in ovarian epithelial tumors.
Lee H; Park G; Jung JH; Ahn WS; Lee JM; Kim BK; Kang CS
Int J Gynecol Cancer; 2005; 15(3):453-61. PubMed ID: 15882169
[TBL] [Abstract][Full Text] [Related]
60. Pathogenesis of ovarian cancers.
Berchuck A; Elbendary A; Havrilesky L; Rodriguez GC; Bast RC
J Soc Gynecol Investig; 1994; 1(3):181-90. PubMed ID: 9419769
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
